by Deloitte
Acquiring an overseas company can open up new markets and business opportunities. However, foreign companies may also include a number of unique human capital considerations that can impact deal value. Latin America, for one, may be a particularly attractive region for foreign acquirers, with a growing middle class and wealth of natural resources. […] Read more
by A.M. Best
David King arrives at M&A integration meetings with laminated sheets of paper. On each page is the rationale behind the merger or acquisition — the “deal thesis.” King, who advises companies on post-M&A integration, wants to make sure management teams keep their eye on the ball, so he hands each team member a copy of the deal thesis. […] Read more
by Willis Towers Watson
In 2012, an event occurred that went largely unnoticed. For the first time, the percentage of Asia Pacific-headquartered companies in the Fortune Global 500 outnumbered those headquartered in Europe and North America. That year, 36% of companies in the Fortune Global 500 were headquartered in Asia Pacific. Of these 181 organisations, 69 were headquartered in Mainland China and 68 in Japan. […] Read more
by Ernst & Young
Our latest Global Capital Confidence Barometer continues to find a strong acquisition appetite together with a growing inclination to forge new alliances. Prolonged economic challenges are driving investment decisions, leading companies to ally and cooperate to generate growth as well as compete and acquire to gain market share. […] Read more
by KPMG
While the number of completed pharma deals were slightly higher in Q1 2016 versus Q1 2015, deal value was far lower in the absence of any >$10 billion completions. Only one deal exceeded $5 billion in Q1 2016 (versus 8 in Q1 2015). Specialization continues to be a driving force in Q1 2016, especially in sectors such as OTC, rare diseases and oncology. Declines in transaction values were also witnessed in chemicals. Downstream specialty chemicals was the leading focus area, notably in applications, resins and agrochemicals. […] Read more
by KPMG
This is an era of unprecedented change for the insurance sector. New technologies, new customer expectations, new regulations and new competitive pressures are rapidly disrupting the traditional insurance business model. In this environment, insurance organizations have no choice but to adapt. The good news is that the vast majority of insurance executives intuitively know they need to be more innovative. […] Read more
by Willis Towers Watson
The number of M&A deals completed in the first quarter of 2016 was the lowest for two years according to Willis Towers Watson’s Quarterly Deal Performance Monitor (QDPM). The research, run in partnership with Cass Business School, shows that despite the fall in completed deals over $100m this quarter (216) compared to 233 in Q1 2015 (and 307 in Q4 2015), financial outperformance for companies completing M&A deals remains positive at 5.3 percentage points (pp) above the MSCI World Index. […] Read more
by KPMG
The latest deals data shows that the volume of developed market investments into emerging markets (D2E) hit a 10-year low over the second half of 2015, but emerging market deals with one another showed strong growth over the same period. Between July and December 2015, the number of D2E deals fell by 3 percent to 541, the lowest number in 10 years. The yearly total is also the lowest in 10 years, at 1101 D2E deals, 9 percent down on 2014. […] Read more
by Mercer
Talent scarcity and the maintaining of talent during M&A activity are prime considerations that must be factored into any such deals. The spiraling amount of global M&A activity undertaken and the pressures and complexities they entail demand an elevated approach to human capital management and the risks that confront every buyer and seller. […] Read more
Trainings
In order to become a charterholder you need to complete one of the IMAA programs
